- Report
- May 2024
- 64 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- December 2024
- 53 Pages
Global
From €2274EUR$2,499USD£1,950GBP
- Report
- December 2024
- 43 Pages
Global
From €3636EUR$3,995USD£3,117GBP
- Report
- December 2024
- 65 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- November 2024
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- October 2024
- 80 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- September 2024
- 42 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- September 2024
- 115 Pages
Global
From €13647EUR$14,995USD£11,699GBP
- Report
- August 2024
- 63 Pages
Global
From €3181EUR$3,495USD£2,727GBP
- Report
- June 2024
- 54 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- May 2024
- 75 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- May 2024
- 92 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- January 2025
- 147 Pages
Global
From €2639EUR$2,900USD£2,263GBP
- Report
- January 2025
- 156 Pages
Global
From €2639EUR$2,900USD£2,263GBP
- Report
- January 2025
- 143 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- January 2025
- 154 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- January 2025
- 148 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- December 2024
- 150 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- July 2024
- 153 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- January 2025
- 98 Pages
Global
From €3500EUR$4,120USD£3,106GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more